SCHEMBL7744663

SCHEMBL7744663

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.76
FLT1 P17948 1/20 0.76
FLT4 P35916 1/20 0.76
KDM4E B2RXH2 3/20 0.49
HDAC1 Q13547 2/20 0.49
APOBEC3A P31941 1/20 0.49
GFER P55789 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
NR4A2 P43354 1/20 0.46
EGFR P00533 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
PIK3CG P48736 1/20 0.43
ALOX15 P16050 1/20 0.42
TSHR P16473 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC2 Q92769 1/20 0.42
NPC1 O15118 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739087 0.94 KDR (0.69) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7746616 0.92 KDR (0.65) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7739078 0.90 KDR (0.68) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7739014 0.90 KDR (0.63) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7746639 0.89 KDR (0.61) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7744662 0.89 KDR (0.61) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7739009 0.89 KDR (0.77) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7739015 0.88 KDR (0.68) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7739018 0.88 KDR (0.62) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7746598 0.87 KDR (0.58) KDRFLT1FLT4HDAC1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed